Data Presented Today Show ARIMIDEX(R) Combined With Herceptin(R) Extended Progression-Free Survival In Patients With Advanced Breast Cancer
Fri, 15 Dec 2006 08:00 AM EST
... Data was presented today showing that postmenopausal women who received ARIMIDEX (anastrozole) and Herceptin (trastuzumab) in combination had a significant improvement in progression-free survival when treated for advanced breast cancer that was both human epidermal growth factor receptor-2 (HER-2)-positive and hormone receptor-positive. [click link for full article] ...
Related Topics
- Anastrozole
- Trastuzumab
- Breast Cancer
- Metastatic Cancer
- Prostate Cancer
- Brain Cancer
- Data & Statistics
- Bone Cancer
- Data Analysis
- Mammograms
- Esophageal Cancer
- Kidney Cancer
- Liver Cancer
- National Data
- Breast Lumps & Other Breast Conditions
- Cancers
- Ovarian Cancer
- Lung Cancer
- Male Breast Cancer
- Breast Cancer, Male

Not Signed In -


